Objective: Native aortic valve calcium and transcatheter aortic valve oversize have been reported to predict pacemaker implantation after transcatheter aortic valve insertion. We reviewed our experience to better understand the association.
See Editorial Commentary page 1063.
Permanent pacemaker implantation occurs in approximately 30% of patients as a complication of transcatheter aortic valve insertion (TAVI). [1] [2] [3] [4] Because some degree of transcatheter valve oversize is needed to securely seat the prosthesis, it is not surprising some studies support that the amount of transcatheter valve oversize and aortic valve calcium are directly associated with postoperative pacemaker implantation. [5] [6] [7] [8] [9] It was our hypothesis that transcatheter valve oversize and aortic valve calcium score would influence the need for pacemaker implantation. We reviewed our single-center experience to better characterize the effect these factors had on postoperative pacemaker implantation.
MATERIALS AND METHODS
The purpose of this study was to determine whether transcatheter aortic valve oversize and native aortic valve calcium were predictive of pacemaker implantation after TAVI. We proposed a multivariate model using the 2 variables and controlling for factors previous identified from the literature to be associated with pacemaker implantation. The Mayo Clinic Institutional Review Board approved this study.
We retrospectively reviewed the records of 435 patients without a previous permanent pacemaker who underwent TAVI between November 2008 and February 2015. There were 126 patients (29.6%) excluded from study because of inadequate computed tomography (CT) scan data, which included patients who were part of the PARTNER studies that did not initially require specific CT scan analysis of the aortic valve and left ventricular outflow tract. 1, 2, 10 An additional 9 patients (2.1%) were excluded from the study because of operation-related death. A total of 300 patients were entered into the study, and all patients received TAVI under general anesthesia ( Figure 1 ).
Baseline patient, electrocardiography, and operative characteristics and 30-day outcome data were abstracted from the Division of Cardiovascular Surgery database and individual patient electronic medical records. Baseline patient characteristics were defined as outlined in the Society of Thoracic Surgeons Adult Cardiac Surgery Database (Society of Thoracic Surgeons, Chicago, Ill). Balloon-expandable valves were sized on the basis of CT-derived aortic valve annulus area, and self-expanding valves were sized on the basis of CT-derived aortic valve annulus perimeter. 11, 12 All patients received a preoperative electrocardiography-gated CT scan of the heart, first without contrast and then with contrast. Calcium quantification was performed using semiautomated software (Syngovia, Siemens Healthcare, Erlangen, Germany) and reported as Agatston units. Native aortic valve annulus area and perimeter were derived using the semiautomated polygon tool (Aquarius iNtuition, TeraRecon, Foster City, Calif) using hand placement of seed points oriented to the plane of the native aortic valve cusp tips.
Valve area oversize was determined on the basis of the equation ([prosthetic aortic valve area O native aortic valve annulus area] À 1) 3 100. 13 Perimeter oversize was determined on the basis of a similar equation: ([prosthetic aortic valve perimeter O native aortic valve annulus perimeter] À 1) 3 100. Transcatheter prosthetic aortic valve areas and perimeters are reported in Table 1 Native aortic valve calcium score and transcatheter valve oversize along with other electrocardiography and valve characteristics identified with pacemaker implantation in previous studies and any additional univariate significant variables were included in a multivariable logistic model. The cohort also was stratified by valve type (ie, self-expanding) to account for the difference in oversize calculation method (eg, area vs perimeter) while controlling for bundle branch block. Data were analyzed with SAS statistical software version 9.4 (SAS Institute, Inc, Cary, NC). An alpha level of 0.05 was used to determine statistical significance.
RESULTS
Baseline patient characteristics included an age of 81.1 AE 8.4 years, female sex in 135 patients (45.0%), and a Society of Thoracic Surgeons predicted risk of mortality of 7.6% (IQR, 5.3-10.6). Additional baseline patient data are presented in Baseline characteristics were similar in patients who received balloon or self-expanding transcatheter prosthetic aortic valve insertion (Table 3 ). Baseline PR interval was less in the balloon-expandable group (184; IQR, 164-210) than in the self-expanding group (173; IQR, 154-199; P ¼ .048), but there was no difference in the number of patients with PR interval greater than 200 ms (P ¼ .219). Right bundle branch block was present in 39 patients (16.0%) in the balloon-expandable valve group and in 6 patients (10.7%) in the self-expanding valve group (P ¼ .319). The prevalence of left bundle branch block was similar in the 2 groups (P ¼ .475).
CT findings were similarly distributed among the balloon-expandable and self-expanding valve insertion groups (Table 3 ). This specifically included aortic valve calcium score that measured 2569 (IQR, 1805-3553) Agatston units in the balloon-expandable valve group and 2509 (IQR, 1684-3460) Agatston units in the self-expanding valve group (P ¼ .488). The native aortic valve area measured 467 AE 78 mm 2 in the balloon-expandable valve group and 487 AE 99 mm 2 in the self-expanding valve group (P ¼ .139).
Aortic valve oversize in the balloon-expandable group was 9.6% (IQR, 1.8-15.9). It is important to note that the self-expanding group was sized by perimeter, and the amount of perimeter oversize was 13.8% (IQR, 7.8-17.5); when this group was analyzed by area, the amount of area oversize was 40.0% (IQR, 27.0-57.1). The difference in the amount of oversize by area was significant between the 2 valve type groups (P <.001).
Postoperative permanent pacemaker implantation was performed in 59 patients (19.7%). Specific valve type and pacemaker implantation rates are reported in Table E1 . The most common indication for pacemaker implantation was advanced atrioventricular block to include complete and high-degree atrioventricular block, which was present in 38 patients (64.4%). The most common device inserted was a dual-chamber right ventricular pacemaker in 41 patients (69.5%). Additional data about pacemaker implantation indications and type of device inserted are reported in Table E2 .
Valve area oversize (%) (unadjusted P ¼ .004) and aortic valve calcium score (unadjusted P ¼ .226) were assessed in a multivariable logistic regression model to control for confounding baseline electrocardiography and valve characteristics known to be associated with pacemaker implantation from previous studies and our Table 4 . The functional forms of valve oversize area and aortic valve calcium score were assessed; the log form of aortic valve calcium score and the untransformed valve oversize area were found to be most appropriate. Aortic valve calcium score (adjusted P ¼ .275) and valve area oversize (adjusted P ¼ .833) were found not to be independently associated with pacemaker implantation. Insertion of a self-expanding transcatheter prosthetic aortic valve was predictive of permanent pacemaker implantation (adjusted OR, 4.09; 95% CI, 1.53-10.96) along with right bundle branch block (adjusted OR, 3.49; 95% CI, 1.61-7.55). However, PR interval greater than 200 ms, previous valve surgery, previous percutaneous intervention, and left bundle branch block were not associated with pacemaker implantation (Table 4) .
In univariate analysis, valve oversize was associated with pacemaker implantation (OR, 1.02; 95% CI, 1.01-1.03; P ¼ .004), but this association disappeared when controlling for self-expanding valve. The interaction of self-expanding valve and valve area oversize in the multivariable model was considered but was not significant (P ¼ .73); however, valve oversize between the 2 groups Logistic regression was performed individually for balloon-expanding and self-expanding valves comparing valve oversize using the area oversize and perimeter oversize, respectively, while controlling for right bundle branch block. Valve oversize was not significantly associated with pacemaker implantation in either group, balloonexpandable (adjusted OR, 0.99; 95% CI, 0.96-1.02; P ¼ .599) for oversize area and self-expanding (adjusted OR, 1.04; 95% CI, 0.96-1.13; P ¼ .320) for perimeter oversize, as shown in Tables 5 and 6 .
There were 126 patients (29.6%) who were excluded from the study because of incomplete CT scan data. Table  E3 contains specific data of baseline patient characteristics, operative data, and outcomes from these patients compared with the 300 patients (70.4%) included in the study.
DISCUSSION
The focus of this study was to test whether aortic valve oversize and calcium score were predictive of permanent pacemaker implantation after TAVI. In this series of 300 patients, pacemaker implantation was performed in 59 patients (19.6%). Standard logistic regression analysis was performed of baseline patient electrocardiographic and valve characteristics to identify those variables associated with pacemaker implantation. Multivariable analysis identified that baseline right bundle branch block and insertion of the self-expanding transcatheter valve were variables independently associated with pacemaker implantation. In contrast, aortic valve oversize and calcium score were not predictive of pacemaker implantation.
There is controversy in the literature whether aortic valve calcium score is related to permanent pacemaker implantation after transcatheter valve insertion. Latsios and colleagues 8 demonstrated that device landing zone calcification was predictive of permanent pacemaker implantation (OR, 1.06; 95% CI, 1.02-1.11; P ¼ .004), but there were only 81 patients in that study. Although Haensig and colleagues 9 reported a ''trend towards a higher incidence of new pacemaker implantation'' (OR, 1.27; 95% CI, 0.85-1.89), specific review of the article demonstrates that the finding was not significant (P ¼ .26). It may be that the aortic valve calcium score is too generalized a measurement, and that it is specific calcification around the area of the membranous septum and atrioventricular conduction system that is important. At present, the current weight of evidence supports no interaction between the aortic valve calcium score and the need for permanent pacemaker implantation after TAVI.
We also noted no relationship between permanent pacemaker implantation and valve area oversize. Similar results were reported by Bleiziffer and colleagues, 14 who noted no association with annulus-to-valve size difference (P ¼ .113). In the study referenced by Nazif and colleagues 5 with the PARTNER Trial and Registry, however, permanent pacemaker implantation was predicted by prosthesis diameter/left ventricular outflow tract diameter (for each 0.1 increment, OR, 1.29; 95% CI, 1.10-1.51; P ¼ .002). But Nazif and colleagues' study was limited to only balloonexpandable valves, and the left ventricular outflow tract diameter was determined with a single plane echocardiography measurement, not with electrocardiography-gated multidetector CT measurement of the aortic valve area, as in the current study.
Postoperative permanent pacemaker implantation is more common after TAVI of a self-expanding valve in comparison with a balloon-expandable valve. The finding is corroborated by our data and in the CHOICE randomized clinical trial reported by Abdel-Wahab and colleagues, 15 who demonstrated that placement of a new permanent pacemaker was less frequent after balloon-expandable valve insertion (17.3%) in comparison with self-expanding valve insertion (37.6%; P ¼ .001). Additional support comes from the Cleveland Clinic group, who published a recent meta-analysis on approximately 30,000 patients undergoing transcatheter valve insertion. 16 In that study, the pooled incidence rates for permanent pacemaker implantation were 6.2% (95% CI, 5.4-7.0) for balloon-expandable valves and 24.3% (95% CI, 20.6-28.1) for self-expanding valves.
Acknowledged reasons for the increased risk of postoperative pacemaker implantation with self-expanding valves are that the prosthesis deploys lower in the left ventricular outflow tract and that continuous outward radial force of the prosthesis can result in injury to the atrioventricular conduction system. 17 It is interesting that in our study, the self-expanding valves had significantly greater amount of valve area oversize (4.6-fold greater) in comparison with the balloon-expandable valves. Although we demonstrated that the amount of area oversize did not predict the need for permanent pacemaker implantation, the vastly greater amount of valve area oversize is a cause for concern. It is possible that newer delivery systems (AccuTrak, Medtronic) and less implantation depth may result in a lower rate of permanent pacemaker implantation, 18, 19 and further study is warranted.
Our data demonstrate a direct relationship between right bundle branch block and risk of permanent pacemaker placement. Additional support of this finding comes from Koos and colleagues, 20 who reported in a small series that 67% of patients with right bundle branch block received a permanent pacemaker after transcatheter valve insertion; along similar lines, Ramazzina and colleagues 21 also reported a predictor of high-grade atrioventricular block was right bundle branch block (OR, 81.95; 95% CI, 8.72-770.46; P<.001). The issue remains controversial because Bleiziffer and colleagues 14 noted a similar prevalence of preoperative right bundle branch block in patients with (9%) and without (2%) new-onset atrioventricular block (P ¼ .078). Similar to our findings, Bleiziffer and colleagues also reported no association with preoperative heart rhythm (ie, sinus rhythm vs atrial fibrillation; P ¼ .869) or left bundle branch block (P ¼ .504).
Study Limitations
This was a single-center, retrospective analysis and therefore is subject to the biases of our multidisciplinary heart team. Although the study included 300 patients, there were only 59 events, so we were limited in how many variables could be entered into the multivariable analysis. We also recognize that more than one third of the patients received a pacemaker for reasons other than high-grade atrioventricular block, which theoretically should be independent of aortic valve calcium score or valve oversize. Our pacemaker insertion practice certainly has evolved with experience from the first to the second decile of implantation, and this bias is difficult to control for given the relatively large number of first decile patients who were excluded from study because of incomplete CT scan data (Table E3 ).
An additional limitation warranting discussion is that we did not address the depth of valve deployment within the left ventricular outflow tract. The depth of deployment has been shown to be related to subsequent permanent pacemaker implantation. However, we would argue that the final position of the valve is mostly important as a postoperative finding. It is our experience that before valve deployment, the position of the valve is exactly where the heart team agrees the deployment should occur. Now, the final position may not be the same because the valve moves some during deployment. There is not much that can be done about that, however, given the valves used in this study (ie, no repositionable valves).
CONCLUSIONS
Pacemaker implantation is common after TAVI and occurred in 1 of 5 patients in this study. Baseline right bundle branch block and insertion of a self-expanding transcatheter aortic prosthesis were predictive of permanent pacemaker insertion, but aortic valve calcium score and valve oversize were not. A better understanding of causation is warranted given the high prevalence of pacemaker implantation. Specifically identifying areas of high focal calcium burden in the area of the left ventricular outflow tract may be more representative of the risk of pacemaker implantation. The ability to recapture and reposition the valve in the proper location seems to be an intuitive method to reduce injury to the atrioventricular conduction system. Knowledge and technology are most likely the keys to the dilemma. 
